For the quarter ending 2026-03-31, ORGO has $519,992K in assets. $138,645K in debts. $91,379K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 91,379 | 93,679 | 63,745 | 73,076 |
| Restricted cash | 720 | 652 | 627 | 659 |
| Accounts receivable, net | 116,908 | 217,451 | 168,783 | 120,382 |
| Inventories, net | 28,425 | 29,627 | 39,583 | 33,042 |
| Asset held for sale | 2,425 | 2,425 | 4,365 | 5,287 |
| Prepaid expenses and other current assets | 28,644 | 18,354 | 22,646 | 27,777 |
| Total current assets | 268,501 | 362,188 | 299,749 | 260,223 |
| Property and equipment, gross | - | 165,075 | 134,619 | - |
| Accumulated depreciation | - | 88,107 | 84,103 | - |
| Construction in progress | - | 26,743 | 27,542 | - |
| Property and equipment, net | 104,078 | 103,711 | 78,058 | 75,607 |
| Intangible assets, net | 3,437 | 9,145 | 9,943 | 10,785 |
| Goodwill | 28,772 | 28,772 | 28,772 | 28,772 |
| Operating lease right-of-use assets, net | 53,742 | 55,749 | 33,304 | 35,257 |
| Deferred tax asset, net | 45,333 | 29,962 | 45,591 | 41,754 |
| Other assets | 16,129 | 9,203 | 14,410 | 8,730 |
| Total assets | 519,992 | 598,730 | 509,827 | 461,128 |
| Current portion of finance lease obligations | 508 | 9,435 | 1,207 | 1,217 |
| Current portion of operating lease obligations - related party | 4,451 | 4,258 | 3,798 | 3,755 |
| Current portion of operating lease obligations | 4,764 | 4,949 | 4,785 | 4,796 |
| Accounts payable | 28,615 | 31,949 | 40,219 | 29,723 |
| Accrued expenses and other current liabilities | 37,683 | 49,533 | 40,310 | 26,348 |
| Total current liabilities | 76,021 | 100,124 | 90,319 | 65,839 |
| Finance lease obligations, net of current portion | 12,358 | 12,788 | 2,094 | 98 |
| Operating lease obligations, net of current portion - related party | 26,993 | 28,237 | 5,419 | 6,385 |
| Operating lease obligations, net of current portion | 21,787 | 22,470 | 23,507 | 24,565 |
| Other liabilities | 1,486 | 1,193 | 2,509 | 3,022 |
| Total liabilities | 138,645 | 164,812 | 123,848 | 99,909 |
| Series a redeemable convertible preferred stock, 0.0001 par value 130,000 shares authorized, issued and outstanding at march 31, 2025 and december 31, 2024 liquidation preference of 134,014 and 131,387 at march 31, 2025 and december 31,2024, respectively | 136,792 | 133,789 | 130,851 | 127,977 |
| Common stock, 0.0001 par value 400,000,000 shares authorized 127,582,084 and 126,458,784 shares issued 126,853,536 and 125,730,236 shares outstanding at march 31,2025 and december 31, 2024 , respectively | 13 | 13 | 13 | 13 |
| Additional paid-in capital | 300,776 | 303,194 | 301,893 | 301,574 |
| Accumulated deficit | -56,234 | -3,078 | -46,778 | -68,345 |
| Total stockholders' equity | 244,555 | 300,129 | 255,128 | 233,242 |
| Total liabilities, redeemable convertible preferred stock, and stockholders' equity | 519,992 | 598,730 | 509,827 | 461,128 |
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. (ORGO)